Many of the booths feature hands-on activities and giveaways, and a main stage will feature engaging presentations. Silver ...

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.

Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

IO Biotech was named to Fast Company's World's Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...

Dynavax’s battle with activist investor Deep Track Capital over the biopharma’s direction has heated up again as the ...